PMDA — authorised 9 February 2010
- Marketing authorisation holder: Santen Pharmaceutical
- Status: approved
🇯🇵 Up4U in Japan
PMDA authorised Up4U on 9 February 2010
Marketing authorisation
Up4U in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Ophthalmology approved in Japan
Frequently asked questions
Is Up4U approved in Japan?
Yes. PMDA authorised it on 9 February 2010.
Who is the marketing authorisation holder for Up4U in Japan?
Santen Pharmaceutical holds the Japanese marketing authorisation.